Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1353027

registered interest
date	06/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the data and evidential basis which supports the decision of the Joint Committee on Vaccination and Immunisation to authorise administration of a covid-19 vaccine to people aged 16 and 17.
tabling member constituency	Gateshead
tabling member printed	Ian Mearns
uin	43491
answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s advice on vaccination of those aged 16 to 17 years old was published on 4 August 2021. The statement sets out the basis for the advice and includes references to supporting evidence and is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years" target="_blank">https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 16:39:03 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4000 label Biography information for Ian Mearns

1352198

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether people who normally receive a flu vaccination, including people with asthma and lung conditions, will receive a covid-19 booster vaccination in autumn 2021.
tabling member constituency	Leeds Central
tabling member printed	Hilary Benn
uin	41664
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccinations should first be offered to the most vulnerable. The JCVI advises a two stage approach, with individuals in stage one offered a booster vaccine and flu vaccine, as soon as possible from September. Individuals in stage two would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests those aged 16 to 49 years old who are in an influenza or COVID-19 at risk group, including some patients with chronic respiratory disease and asthma are currently included in stage two.</p><p>Final decisions on the timing and scope and cohort eligibility, booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 42174 question first answered 08/09/2021 15:14:12 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	413 label Biography information for Hilary Benn

1352544

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the findings of (a) the ONS that chronic lower respiratory disease is the third most common underlying condition with death as a result of covid-19 in quarter 2 of 2021 and (b) of the British Lung Foundation, in its 2012 survey, that 81 per cent of chronic lower respiratory disease is asthma, if he will make it his policy that people with asthma who receive a free annual flu vaccination will be included in any covid-19 booster vaccination programme.
tabling member constituency	North Norfolk
tabling member printed	Duncan Baker
uin	42174
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation’s (JCVI) interim advice is that COVID-19 booster vaccinations should first be offered to the most vulnerable. The JCVI advises a two stage approach, with individuals in stage one offered a booster vaccine and flu vaccine, as soon as possible from September. Individuals in stage two would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests those aged 16 to 49 years old who are in an influenza or COVID-19 at risk group, including some patients with chronic respiratory disease and asthma are currently included in stage two.</p><p>Final decisions on the timing and scope and cohort eligibility, booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41664 question first answered 08/09/2021 15:14:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4784 label Biography information for Duncan Baker

1352693

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to provide similar guidance to the temporary clinical authorisation granted by the Medicine and Healthcare Products Regulatory Agency (MHRA) to the Pfizer/BioNtech vaccine on 2 December 2020, to the MHRA in regards to the fast-tracking of nasal covid-19 vaccines; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	41742
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>COVID-19 vaccines which can be administered nasally are currently in early clinical trials. Any route to approval of such treatments will be subject to the developer seeking regulatory approval from the United Kingdom’s independent medicines regulator, the Medicines and Healthcare products Regulatory Agency.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 13:59:54 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker

1350856

registered interest
date	18/08/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	New Businesses: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support start-ups in the manufacturing sector.
tabling member constituency	Wolverhampton South West
tabling member printed	Stuart Anderson
uin	41272
answer	answer is ministerial correction date of answer 09/09/2021 answer text <p>The Government is committed to supporting UK manufacturing businesses, including start-ups and recognises the vital role they play in the UK economy, by driving innovation, exports, job creation and productivity growth.</p><p> </p><p>We are committed to supporting manufacturers to take advantage of innovative technology and we recently announced <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2F8-million-government-boost-for-manufacturers-across-england-to-go-digital&amp;data=04%7C01%7Cfilder.onek%40beis.gov.uk%7Caa8df0a9fa1b47253ef508d966631201%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637653397946777930%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=JbjtVD2pKuArzY4hKwXd7ZbWr5lCJDL85VcFmQvt5pw%3D&amp;reserved=0" target="_blank">£8 million in new government funding for the Made Smarter Adoption programme to help Small and Medium Sized Enterprises (SMEs</a>) increase productivity, competitiveness and drive up efficiency by adopting industrial digital technology, building on the success of our Made Smarter North West Pilot.</p><p> </p><p>The Government’s business support schemes have been put in place to help eligible businesses to get through the pandemic, from all regions and backgrounds. Information on these schemes and other resources is available via the free Business Support Helpline.</p><p> </p><p>The Start Up Loans Company, part of the Government-owned British Business Bank, provides loans and pre- and post-application support to new entrepreneurs, including a year of free business mentoring for successful applicants. Since 2012, over 86,000 Start Up Loans worth over £769 million have been issued to new entrepreneurs. We are also investing £147 million through the Made Smarter Innovation programme to help forward-thinking UK manufacturers create new, green products and processes, slash carbon emissions, drive up productivity and create thousands of highly skilled new jobs across the country.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/09/2021 12:39:38 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4742 label Biography information for Stuart Anderson

1350957

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce covid-19 vaccine wastage; and what action is taken with unused vaccines.
tabling member constituency	Birmingham, Ladywood
tabling member printed	Shabana Mahmood
uin	40820
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>No vaccines should be wasted. All vaccination centres should have a backup list of people in the cohorts currently being vaccinated, who can be called in case doses would be wasted. This is in line with the Enhanced Service Specification for the COVID-19 vaccination programme 2020/21.</p><p>We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction, including, where there is data to support it, looking at the extension of expiry dates.</p><p>The United Kingdom is also one of the largest donors to COVID-19 Vaccines Global Access (COVAX). We will donate at least 100 million surplus doses within the next year, with the first batch of five million already delivered last month.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:43:56 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3914 label Biography information for Shabana Mahmood

1350995

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people who have received two covid-19 vaccinations, including Oxford AstraZeneca batch numbers (a) 4120Z001, (b) 4120Z002 and (c) 4120Z003, are able to travel to EU countries.
tabling member constituency	Halifax
tabling member printed	Holly Lynch
uin	41025
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The European Union has recently published a list of vaccines it sees as equivalent to those authorised by the European Medicines Agency, for travel purposes which is at the following link:</p><p> </p><p><a href="https://reopen.europa.eu/en" target="_blank">https://reopen.europa.eu/en</a></p><p> </p><p>The list includes all vaccines administered in the United Kingdom, including all batches of AstraZeneca vaccine administered in the UK known commercially as Vaxzevria. This also includes batches 4120Z001, 4120Z002 and 4120Z003. Decisions on which vaccines EU Member States will accept at their borders is for those countries to decide. We are not aware that any have decided not to accept UK vaccines.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:15:23 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4472 label Biography information for Holly Lynch

1351014

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department has had with its counterpart in Italy in respect of British tourists' entry to Italy whose covid-19 vaccine was manufactured at Serum Institute in India.
tabling member constituency	Meriden
tabling member printed	Saqib Bhatti
uin	41357
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield vaccines and both branded vaccines are exactly the same COVID-19 AstraZeneca vaccine. All SII-made doses approved by the United Kingdom (UK) regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’.</p><p> </p><p>The government continues to liaise with counterparts in Italy and we are seeking Italian confirmation that they will recognise all AstraZeneca doses administered in the UK. We will ensure that Foreign, Commonwealth and Development Office Travel Advice is kept up to date following any developments.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:10:14 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4818 label Biography information for Saqib Bhatti

1351023

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Quarantine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason Government policy makes a distinction between covid-19 vaccines received in the UK and those received overseas when deciding whether a traveller returning from an amber list country needs to quarantine.
tabling member constituency	Plymouth, Sutton and Devonport
tabling member printed	Luke Pollard
uin	41240
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>The Government is currently undertaking extensive work to consider which regulators and associated vaccines we would recognise. It is important to consider which regulators have similar stringent standards of authorisation as the Medicines Healthcare products Regulatory Agency, which has some of the highest standards of quality, safety and efficacy in the world. This will then feed into discussions regarding quarantine from amber-listed countries.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:22:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4682 label Biography information for Luke Pollard

1351024

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether there is a material difference in terms of (a) medical and (b) public health effect between covid-19 vaccines administered overseas and those administered domestically by the NHS.
tabling member constituency	Plymouth, Sutton and Devonport
tabling member printed	Luke Pollard
uin	41241
answer	answer is ministerial correction date of answer 07/09/2021 answer text <p>Comparisons between vaccines administered across the world are complex due to differences in vaccine trials and monitoring. When a vaccine receives a marketing authorisation or conditional marketing authorisation from a medicines regulator, certain factors or conditions are specified by the national regulator in order to ensure the product is of the highest quality, safety and efficacy for authorisation.</p><p>We are currently considering which regulators and associated vaccines we would be confident to recognise in the United Kingdom.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/09/2021 15:06:24 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4682 label Biography information for Luke Pollard